Lipigon Pharmaceuticals AB - ESG Rating & Company Profile powered by AI
The Disclosure score covers 17 UN Sustainable Development Goals including: 'Good Health & Wellbeing', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'. If you are employed by Lipigon Pharmaceuticals AB and you would like to use your Sustainability aseessment, please get in touch. The page contains a Q&A table for Lipigon Pharmaceuticals AB.
Lipigon Pharmaceuticals AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 2.7, social score of 8.0 and governance score of 4.0.
4.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1047 | SQZ Biotechnologies Co | 5.0 | High |
| 1047 | Zenabis Global Inc | 5.0 | High |
| 1082 | Lipigon Pharmaceuticals AB | 4.9 | High |
| 1082 | AngioLab Inc | 4.9 | High |
| 1082 | Annexon Inc | 4.9 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Lipigon Pharmaceuticals AB have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose current and historical energy intensity?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB report the average age of the workforce?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose its ethnicity pay gap?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose cybersecurity risks?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB offer flexible work?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB conduct supply chain audits?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB conduct 360 degree staff reviews?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose the individual responsible for D&I?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose water use targets?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB have careers partnerships with academic institutions?
Sign up for free to unlockDid Lipigon Pharmaceuticals AB have a product recall in the last two years?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose incidents of discrimination?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Lipigon Pharmaceuticals AB issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose parental leave metrics?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose the pay ratio of women to men?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Lipigon Pharmaceuticals AB involved in embryonic stem cell research?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose its waste policy?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB report according to TCFD requirements?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose energy use targets?
Sign up for free to unlockDoes Lipigon Pharmaceuticals AB disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Lipigon Pharmaceuticals AB have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Lipigon Pharmaceuticals AB
These potential risks are based on the size, segment and geographies of the company.
Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease and familial chylomicronemia syndrome; a gene therapy project for the lipodystrophy, a rare disease of altered fat distribution in the body; therapeutics for dyslipidemia, a general lipid disorder; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia, cardiovascular disease, and other metabolic diseases. The company was founded in 2010 and is based in Umeå, Sweden.